122 related articles for article (PubMed ID: 3552018)
1. Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia.
Kumar S; Mansel RE; Jasani B
Br J Cancer; 1987 Mar; 55(3):307-9. PubMed ID: 3552018
[TBL] [Abstract][Full Text] [Related]
2. Highly specific sites of prolactin binding in benign and malignant breast tissue.
Agarwal PK; Tandon S; Agrawal AK; Kumar S
Indian J Exp Biol; 1989 Dec; 27(12):1035-8. PubMed ID: 2633963
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
Selim AG; Wells CA
J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
[TBL] [Abstract][Full Text] [Related]
4. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
5. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
6. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study.
Gill S; Peston D; Vonderhaar BK; Shousha S
J Clin Pathol; 2001 Dec; 54(12):956-60. PubMed ID: 11729217
[TBL] [Abstract][Full Text] [Related]
7. Apocrine epithelium of the breast: does it result from metaplasia?
Viacava P; Naccarato AG; Bevilacqua G
Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
Mazoujian G; Pinkus GS; Davis S; Haagensen DE
Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
[TBL] [Abstract][Full Text] [Related]
9. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts.
Wellings SR; Alpers CE
Hum Pathol; 1987 Apr; 18(4):381-6. PubMed ID: 3557440
[TBL] [Abstract][Full Text] [Related]
10. Beta-endorphin, steroids, and prolactin. Immunoassay in breast cysts and blood.
Schön HJ; Schurz B; Wenzl R; Knogler W; Kubista E
Arch Pathol Lab Med; 1993 Mar; 117(3):248-53. PubMed ID: 8442670
[TBL] [Abstract][Full Text] [Related]
11. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
12. Effect of human, bovine and ovine prolactin on DNA synthesis by organ cultures of benign human breast tumours.
Welsch CW; Dombroske SE; McManus MJ; Calaf G
Br J Cancer; 1979 Dec; 40(6):866-71. PubMed ID: 575047
[TBL] [Abstract][Full Text] [Related]
13. Early apocrine change in hyperplastic cystic disease.
Vilanova JR; Simon R; Alvarez J; Rivera-Pomar JM
Histopathology; 1983 Sep; 7(5):693-8. PubMed ID: 6195070
[TBL] [Abstract][Full Text] [Related]
14. Use of the dinitrophenyl hapten sandwich staining procedure (DHSS) to localize estrogen receptors in paraffin-embedded tissues.
Gee JM; Amselgruber WM; Jasani B; Nicholson RI
J Histochem Cytochem; 1991 Dec; 39(12):1659-70. PubMed ID: 1719072
[TBL] [Abstract][Full Text] [Related]
15. Lectin binding in the male breast.
Raju GC; Lee YS
J Pathol; 1988 Sep; 156(1):45-50. PubMed ID: 3193300
[TBL] [Abstract][Full Text] [Related]
16. Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia.
Tschugguel W; Knogler W; Czerwenka K; Mildner M; Weninger W; Zeillinger R; Huber JC
Br J Cancer; 1996 Nov; 74(9):1423-6. PubMed ID: 8912539
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha 2 glycoprotein.
Bundred NJ; Miller WR; Walker RA
Histopathology; 1987 Jun; 11(6):603-10. PubMed ID: 3305282
[TBL] [Abstract][Full Text] [Related]
18. Uneven distribution and significant concentration of apocrine metaplasia in lower breast quadrants.
Benigni G; Squartini F
Tumori; 1986 Apr; 72(2):179-82. PubMed ID: 3705191
[TBL] [Abstract][Full Text] [Related]
19. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
20. Vimentin expression in benign and malignant breast epithelium.
Heatley M; Whiteside C; Maxwell P; Toner P
J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
